Clinical Advances in Dermatology: Pathophysiology, Diagnosis and Treatment
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 20 August 2024 | Viewed by 1241
Special Issue Editors
Interests: psoriasis; atopic dermatitis; urticaria; biosimilars
Special Issues, Collections and Topics in MDPI journals
Interests: psoriasis; atopic dermatitis; urticaria; biosimilars pediatric dermatology; trichology
Special Issue Information
Dear Colleagues,
The eruption of great therapeutic advances in our field, with the incorporation of biological drugs and molecules such as JAK (Janus Kinase) inhibitors, has advanced the knowledge of diagnosis thanks to new scales and results reported by patients that are being included in studies, clinical trials and randomized trials. New therapeutic targets and a better understanding of the pathophysiology of some immune-mediated diseases, such as psoriasis, atopic dermatitis, vitiligo, hidradenitis, urticaria or alopecia areata, have also emerged. In this issue, we will delve into the advances that are taking place in the different fields of clinical dermatology regarding these pathologies.
Dr. Ricardo Ruíz-Villaverde
Dr. Manuel Galán-Gutiérrez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psoriasis
- atopic dermatitis
- laser therapy
- urticaria
- alopecia areata
- treatment
- biological treatment
- JAK (Janus Kinase) inhibitors